Imax price target raised to $28 from $25 at Rosenblatt

Rosenblatt raised the firm’s price target on Imax to $28 from $25 and keeps a Buy rating on the shares. With the headwinds caused by the strikes now in the rearview mirror, Imax is poised for a return to growth and margin expansion, the analyst tells investors in a research note. The firm says the company materially exceeded expectations in Q2 and is entering a period where the film slate is “chock-full of potential hits that can keep the out-performance going.”